You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Copy file name to clipboardExpand all lines: README.md
+1-58Lines changed: 1 addition & 58 deletions
Display the source diff
Display the rich diff
Original file line number
Diff line number
Diff line change
@@ -132,64 +132,7 @@ zip
132
132
- Validated with University of Washington
133
133
134
134
135
-
## What's new in ver 7.1 (September 26, 2018)
136
-
137
-
- Patches to drug blood pressure modifications to restrict pathways to be more physiologically accurate
138
-
- Vasopressin support and validation
139
-
- Major patches to #include requirements, reduction in file dependencies
140
-
- Increases modularity of the project, increase build times during development
141
-
- Change in how we generate code from our CDM XSD files to one file per XSD file instead of per type
142
-
- Reduced build times for the full source from 40 to 10 min
143
-
- empty constructors in SETypes to = default and adding override markers
144
-
- no longer use stdafx.h while compiling and so many headers make direct reference to COmmonDataModel.h and Biogears.h which were previously bundled in these precompiled headers
145
-
- Override functionality now supported in BioGears
146
-
- May override any physiology data request with desired value
147
-
- Logging will document range of possible values if typing unsupported data
148
-
- Engine can now be globally flagged as conformant or non conformant to increase future development possibilities
149
-
- Can be manipulated via action api calls
150
-
- Example xmls and sdks demonstrate functionality
151
-
- Moved all BioGears functionality in to the BioGears namespace
152
-
153
-
154
-
## What's new in ver 7.0 (August 22, 2018)
155
-
156
-
- BioGears python plotting tool
157
-
- Max work rate now a patient parameter and is configurable
158
-
- Hemorrhage action updates, may now specify location and rate
159
-
- Rate will diminish as pressure in the vessel decreases
160
-
- Update build process to be entirely supported by CMAKE
161
-
- Removed Apache Ant dependency
162
-
- Updated build directory and runtime directory dependencies
163
-
- Full build support for ARM platforms
164
-
- Updates to source to support all major platforms: Mac, Windows, Linux, and ARM
165
-
- Updated build architecture to python buildbot libraries
166
-
- 8 concurrent nightly builds to ensure multi-platform support
167
-
- Setup mirroring onto our new github repository
168
-
- All development now open to the community with feature branches also supporting nightly builds
169
-
- Dockerfile and testing/support now supported, see more at https://cloud.docker.com/u/biogears/repository/docker/biogears/engine
170
-
- Pain model and patient pain susceptibility configuration flag
171
-
- Validated pain model supported, stimulus can be specified with severity from 0-1
172
-
- Works with all supported pain medication in the BioGears engine
173
-
- Treat patient with Morphine, Fentynal, and/or Ketamine
174
-
- New How-to-pain file to display sdk support
175
-
- Sepsis model
176
-
- Robust whole body inflammation model with severity and location specifiers in .xml and SDK
177
-
- New How-to-sepsis file to show sdk functionality (command-line tool)
178
-
- Validated treatments with fluid resuscitation guidelines, vasopressin, norepinephrine, and antibiotics
179
-
- Validated blood chemistry markers such as bilirubin, white blood cell count, and lactate
180
-
- New antibiotic IV drip
181
-
- Can be used to treat sepsis
182
-
- Two new supported patients: toughguy and toughgirl
183
-
- Sweat rate patches now meeting validation
184
-
- Better core temperature regulation during exercise
185
-
- Hyper/hypo-hidrosis now a supported patient parameter
186
-
- Updates and new 7.0 java GUI release to support users who want to create their own substance
187
-
- Includes ability to patch in new drugs
188
-
- Chemoreceptor method updated to track validation for hypercapnic and hypoxic conditions
189
-
- Better support for respiratory validation across the board, particularly supported respiratory conditions
190
-
- Patches to saline infusion loading on the patient for better respiratory validation
191
-
192
-
135
+
For a list of historical releases please see our [website](https://www.biogearsengine.com/documentation/index.html).
Copy file name to clipboardExpand all lines: share/doc/markdown/Versioning.md
+124Lines changed: 124 additions & 0 deletions
Display the source diff
Display the rich diff
Original file line number
Diff line number
Diff line change
@@ -13,6 +13,130 @@ This versioning follows the <a href="http://semver.org">Semantic Versioning 2.0.
13
13
14
14
## %BioGears Version History
15
15
16
+
## What's new in ver 7.2 and 7.2.1 (January 29, 2019)
17
+
18
+
- General bug fixes and updates
19
+
- Finalization for testing and implementation to BioGears override functionality with full physiology request data support
20
+
- Arterial and Venous PH data requests
21
+
- Inflammation state data to support sepsis model serialization
22
+
- Generalized sepsis model to a more generic inflammation model
23
+
- Will be critical to future modeling efforts (hemorrhage, burn, infection)
24
+
- New example sepsis xml files (SepsisSevere_Gut.xml)
25
+
- New lymph circuit
26
+
- Handles Albumin transport and re-circulation
27
+
- Creates realistic oncotic pressure sources for substance transport
28
+
- Transport from tissue systems back into the vasculature via lymph
29
+
- New command line utility project (bg-cli) for native c++ runtime, driver, batch run organizer/manager
30
+
- Optional name value for xml actions meal and environment
31
+
- New burn model
32
+
- User defined total body surface area input
33
+
- Inflammation cascade validated for long running scenarios (24 hr +)
34
+
- Validated for traditional treatment protocols with USISR SMEs
35
+
- New unit testing framework (Google Test) to better support multi-platform functionality
36
+
- Unit Test harness is a separate project in CMAKE which can be controlled with Biogears_BUILD_TEST variable
37
+
- Introduced const char* DLL interfaces for all functions dealing with std::string to avoid Windows-related issues dealing with XSD implicitly exporting string through inheritance
38
+
- Updated functionality to tension pneumothorax to fix bug in bilateral behavior
39
+
- Updated hemorrhage bugs to update blood gas levels and metabolic requirements
40
+
- Validated with University of Washington
41
+
42
+
43
+
## What's new in ver 7.1 (September 26, 2018)
44
+
45
+
- Patches to drug blood pressure modifications to restrict pathways to be more physiologically accurate
46
+
- Vasopressin support and validation
47
+
- Major patches to #include requirements, reduction in file dependencies
48
+
- Increases modularity of the project, increase build times during development
49
+
- Change in how we generate code from our CDM XSD files to one file per XSD file instead of per type
50
+
- Reduced build times for the full source from 40 to 10 min
51
+
- empty constructors in SETypes to = default and adding override markers
52
+
- no longer use stdafx.h while compiling and so many headers make direct reference to COmmonDataModel.h and Biogears.h which were previously bundled in these precompiled headers
53
+
- Override functionality now supported in BioGears
54
+
- May override any physiology data request with desired value
55
+
- Logging will document range of possible values if typing unsupported data
56
+
- Engine can now be globally flagged as conformant or non conformant to increase future development possibilities
57
+
- Can be manipulated via action api calls
58
+
- Example xmls and sdks demonstrate functionality
59
+
- Moved all BioGears functionality in to the BioGears namespace
60
+
61
+
62
+
## What's new in ver 7.0 (August 22, 2018)
63
+
64
+
- BioGears python plotting tool
65
+
- Max work rate now a patient parameter and is configurable
66
+
- Hemorrhage action updates, may now specify location and rate
67
+
- Rate will diminish as pressure in the vessel decreases
68
+
- Update build process to be entirely supported by CMAKE
69
+
- Removed Apache Ant dependency
70
+
- Updated build directory and runtime directory dependencies
71
+
- Full build support for ARM platforms
72
+
- Updates to source to support all major platforms: Mac, Windows, Linux, and ARM
73
+
- Updated build architecture to python buildbot libraries
74
+
- 8 concurrent nightly builds to ensure multi-platform support
75
+
- Setup mirroring onto our new github repository
76
+
- All development now open to the community with feature branches also supporting nightly builds
77
+
- Dockerfile and testing/support now supported, see more at https://cloud.docker.com/u/biogears/repository/docker/biogears/engine
78
+
- Pain model and patient pain susceptibility configuration flag
79
+
- Validated pain model supported, stimulus can be specified with severity from 0-1
80
+
- Works with all supported pain medication in the BioGears engine
81
+
- Treat patient with Morphine, Fentynal, and/or Ketamine
82
+
- New How-to-pain file to display sdk support
83
+
- Sepsis model
84
+
- Robust whole body inflammation model with severity and location specifiers in .xml and SDK
85
+
- New How-to-sepsis file to show sdk functionality (command-line tool)
86
+
- Validated treatments with fluid resuscitation guidelines, vasopressin, norepinephrine, and antibiotics
87
+
- Validated blood chemistry markers such as bilirubin, white blood cell count, and lactate
88
+
- New antibiotic IV drip
89
+
- Can be used to treat sepsis
90
+
- Two new supported patients: toughguy and toughgirl
91
+
- Sweat rate patches now meeting validation
92
+
- Better core temperature regulation during exercise
93
+
- Hyper/hypo-hidrosis now a supported patient parameter
94
+
- Updates and new 7.0 java GUI release to support users who want to create their own substance
95
+
- Includes ability to patch in new drugs
96
+
- Chemoreceptor method updated to track validation for hypercapnic and hypoxic conditions
97
+
- Better support for respiratory validation across the board, particularly supported respiratory conditions
98
+
- Patches to saline infusion loading on the patient for better respiratory validation
99
+
100
+
101
+
## What's new in ver 6.3 (March 1, 2018)
102
+
The latest deployment includes the following notable updates:
103
+
104
+
- General bug fixes, system improvements, and tools/solver improvements
105
+
- Fasciculation patient event flags
106
+
- Updated sweat methodology (fixes to ions lost in sweat)
107
+
- Updated substance and compound infusion functionality
108
+
- Added Ringers lactate and updated
109
+
- Saline compound ion concentrations corrected
110
+
- Hardened implementation
111
+
- MuscleMass new patient data request
112
+
- Muscle catabolism patient flag
113
+
- Added dehydration condition
114
+
- Implemented as scalar 0to1 representing fractional total body water lost
115
+
- Fluid removed from patient compartments
116
+
- Updated patient flag for event and track body weight change (validated)
117
+
- Added totalbodyfluidVolume as data request
118
+
- Updated patient weight as a function of condition
119
+
- Added starvation condition
120
+
- TimeSinceMeal determines how long since the patient's last meal
121
+
- Scales internal nutrient storages from validated starvation data
122
+
- Removed ConsumeMeal condition, now replaced by starvation condition
123
+
- Validated blood concentrations for ketones, glucose, and amino acids
124
+
- Updated patient weight as a function of condition
125
+
- Intracellular ion transport
126
+
- Model uses membrane potential (see @ref TissueMethodology for details)
127
+
- Michaelis coefficient could support more ion regulation in the future
128
+
- Gated ion transport allows for differences between intra/extracellular spaces
129
+
- COPD now supports elevated anaerobic metabolism
130
+
- Ion transport model in the small intestine
131
+
- Updated drug library so all drugs support an effects site transport rate
132
+
- Diabetes type 1 and type 2 conditions
133
+
- insulin resistance and insulin production effects
134
+
- Hemorrhage action now initialized with a 0-1 severity and a location (MCIS SDK example still exists)
135
+
- New drug Vasopressin
136
+
- New drug classifications in the CDM for better grouping in-code
137
+
- Include anesthetic, sedative, opioid, and reversal agent
138
+
- More grouping in future work
139
+
16
140
## 6.2 (September 30, 2017)
17
141
18
142
The latest deployment includes the following notable updates:
0 commit comments